| Dr Melissa Schwebach Wood, OD | |
|
2460 India Hook Rd, Suite 206, Rock Hill, SC 29732-3530 | |
| (803) 985-2020 | |
| (803) 985-2021 |
| Full Name | Dr Melissa Schwebach Wood |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 19 Years |
| Location | 2460 India Hook Rd, Rock Hill, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417948175 | NPI | - | NPPES |
| D13876 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1387 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Palmetto Eyecare Associates P A | 4789866963 | 3 |
News Archive
NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study). NeuroVive's advanced CicloMulsion(TM) cremophor-free IV cyclosporine formulation is used in this study of 1,000 patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction to examine cyclosporine's ability to protect cardiac tissue.
Young fathers in Britain should be given a greater financial incentive to become hands-on carers during their child's early years, according to a new report.
A day after the Senate overwhelmingly approved legislation to extend a payroll tax cut for two months, House Republicans made clear Sunday that they would not support the measure. Speaker John A. Boehner, who was among the Republican and Democratic leaders who on Friday had worked out a deal on the $33 billion package, did an about-face on Sunday and said he and other House Republicans were opposed to the temporary extension.
Nature News reports on last week's announcement of preliminary results from a large clinical trial testing the efficacy of GlaxoSmithKline's (GSK) RTS,S malaria vaccine, writing that while media coverage of the announcement touted it as a "big breakthrough in the long campaign to create a malaria vaccine," "several leading vaccine researchers, who are critical of the unusual decision to publish partial trial data, argue that the results raise questions about whether the RTS,S/AS01 candidate vaccine can actually win approval."
Advanced algorithms working from large chemical databases can predict a new chemical's toxicity better than standard animal tests, suggests a study led by scientists at Johns Hopkins Bloomberg School of Public Health.
› Verified 7 days ago
| Provider Name | Palmetto Eyecare Associates P A |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1134364128 PECOS PAC ID: 4789866963 Enrollment ID: O20110309000370 |
News Archive
NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study). NeuroVive's advanced CicloMulsion(TM) cremophor-free IV cyclosporine formulation is used in this study of 1,000 patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction to examine cyclosporine's ability to protect cardiac tissue.
Young fathers in Britain should be given a greater financial incentive to become hands-on carers during their child's early years, according to a new report.
A day after the Senate overwhelmingly approved legislation to extend a payroll tax cut for two months, House Republicans made clear Sunday that they would not support the measure. Speaker John A. Boehner, who was among the Republican and Democratic leaders who on Friday had worked out a deal on the $33 billion package, did an about-face on Sunday and said he and other House Republicans were opposed to the temporary extension.
Nature News reports on last week's announcement of preliminary results from a large clinical trial testing the efficacy of GlaxoSmithKline's (GSK) RTS,S malaria vaccine, writing that while media coverage of the announcement touted it as a "big breakthrough in the long campaign to create a malaria vaccine," "several leading vaccine researchers, who are critical of the unusual decision to publish partial trial data, argue that the results raise questions about whether the RTS,S/AS01 candidate vaccine can actually win approval."
Advanced algorithms working from large chemical databases can predict a new chemical's toxicity better than standard animal tests, suggests a study led by scientists at Johns Hopkins Bloomberg School of Public Health.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melissa Schwebach Wood, OD 2460 India Hook Rd, Suite 206, Rock Hill, SC 29732-3530 Ph: (803) 985-2020 | Dr Melissa Schwebach Wood, OD 2460 India Hook Rd, Suite 206, Rock Hill, SC 29732-3530 Ph: (803) 985-2020 |
News Archive
NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study). NeuroVive's advanced CicloMulsion(TM) cremophor-free IV cyclosporine formulation is used in this study of 1,000 patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction to examine cyclosporine's ability to protect cardiac tissue.
Young fathers in Britain should be given a greater financial incentive to become hands-on carers during their child's early years, according to a new report.
A day after the Senate overwhelmingly approved legislation to extend a payroll tax cut for two months, House Republicans made clear Sunday that they would not support the measure. Speaker John A. Boehner, who was among the Republican and Democratic leaders who on Friday had worked out a deal on the $33 billion package, did an about-face on Sunday and said he and other House Republicans were opposed to the temporary extension.
Nature News reports on last week's announcement of preliminary results from a large clinical trial testing the efficacy of GlaxoSmithKline's (GSK) RTS,S malaria vaccine, writing that while media coverage of the announcement touted it as a "big breakthrough in the long campaign to create a malaria vaccine," "several leading vaccine researchers, who are critical of the unusual decision to publish partial trial data, argue that the results raise questions about whether the RTS,S/AS01 candidate vaccine can actually win approval."
Advanced algorithms working from large chemical databases can predict a new chemical's toxicity better than standard animal tests, suggests a study led by scientists at Johns Hopkins Bloomberg School of Public Health.
› Verified 7 days ago
Dr. William R Hundley, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1220 Ebenezer Road, Rock Hill, SC 29732 Phone: 803-327-2020 Fax: 803-327-2335 | |
Dr. Sakesha Yolonda Caston, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1268 Ebenezer Rd, Rock Hill, SC 29732 Phone: 803-327-2001 | |
Pride Eyecare Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1220 Ebenezer Rd, Rock Hill, SC 29732 Phone: 803-327-2020 Fax: 803-327-2335 | |
Dr. Jonathan M Robinson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1565 Ebenezer Rd, Suite 100, Rock Hill, SC 29732 Phone: 803-328-0168 Fax: 803-325-8473 | |
Daniel Max & Marcandrea, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2316 Cherry Rd, Suite 103, Rock Hill, SC 29732 Phone: 956-335-6476 | |
Palmetto Eyecare Associates P A Optometrist Medicare: Medicare Enrolled Practice Location: 2460 India Hook Rd, Suite 206, Rock Hill, SC 29732 Phone: 803-985-2020 Fax: 803-985-2021 | |
Eye Care Plus, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 2474 Crosspointe Dr, Rock Hill, SC 29730 Phone: 803-329-3937 |